De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Merit Medical Systems Toekomstige groei

Future criteriumcontroles 1/6

Merit Medical Systems zal naar verwachting groeien in winst en omzet met respectievelijk 13.8% en 6.8% per jaar. De winst per aandeel zal naar verwachting groeien met 13.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 10.3% zijn.

Belangrijke informatie

13.8%

Groei van de winst

13.2%

Groei van de winst per aandeel

Medical Equipment winstgroei	17.6%
Inkomstengroei	6.8%
Toekomstig rendement op eigen vermogen	10.3%
Dekking van analisten	Good
Laatst bijgewerkt	20 Sep 2024

Recente toekomstige groei-updates

Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

May 03

Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report

Mar 02

Recent updates

Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price

Aug 22

These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely

Jul 31

Merit Medical Systems: Steady Wins The Day

Jul 05

Merit Medical Systems (NASDAQ:MMSI) Ticks All The Boxes When It Comes To Earnings Growth

Jun 19

Merit Medical: Undervalued With Multiple Growth Drivers In Play

Jun 15

Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price

May 23

It Looks Like Shareholders Would Probably Approve Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Compensation Package

May 09

Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

May 03

Is Merit Medical Systems (NASDAQ:MMSI) Using Too Much Debt?

Apr 30

Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing

Apr 16

When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Apr 02

Merit Medical Systems: Solid Performer, Fully Valued

Mar 03

Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report

Mar 02

We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease

Feb 05

The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing

Jan 23

What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E

Dec 18

These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely

Nov 21

What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?

Nov 06

Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Oct 23

Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?

Sep 11

Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing

Aug 13

Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Jul 31

Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?

Jul 17

Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?

Jun 07

Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?

May 01

We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease

Apr 16

Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes

Apr 02

Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?

Mar 01

Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price

Feb 01

Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Jan 12

Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly

Dec 29

Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching

Nov 23

Winst- en omzetgroeiprognoses

NasdaqGS:MMSI - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	1,526	177	183	249	8
12/31/2025	1,449	147	166	196	11
12/31/2024	1,343	123	125	150	11
6/30/2024	1,301	117	177	218	N/A
3/31/2024	1,283	102	131	167	N/A
12/31/2023	1,257	94	108	145	N/A
9/30/2023	1,226	100	68	111	N/A
6/30/2023	1,198	90	45	95	N/A
3/31/2023	1,173	85	65	117	N/A
12/31/2022	1,151	75	66	114	N/A
9/30/2022	1,136	62	89	132	N/A
6/30/2022	1,116	58	87	122	N/A
3/31/2022	1,101	48	90	124	N/A
12/31/2021	1,075	48	116	147	N/A
9/30/2021	1,054	43	105	138	N/A
6/30/2021	1,031	28	133	168	N/A
3/31/2021	969	4	131	172	N/A
12/31/2020	964	-10	116	165	N/A
9/30/2020	964	-29	96	155	N/A
6/30/2020	963	-30	44	115	N/A
3/31/2020	1,000	-4	16	93	N/A
12/31/2019	995	5	-4	78	N/A
9/30/2019	970	19	-3	75	N/A
6/30/2019	949	39	17	87	N/A
3/31/2019	918	43	24	92	N/A
12/31/2018	883	42	20	87	N/A
9/30/2018	840	40	23	82	N/A
6/30/2018	798	19	8	63	N/A
3/31/2018	760	18	N/A	55	N/A
12/31/2017	728	28	N/A	63	N/A
9/30/2017	695	28	N/A	61	N/A
6/30/2017	672	33	N/A	63	N/A
3/31/2017	637	31	N/A	57	N/A
12/31/2016	604	20	N/A	54	N/A
9/30/2016	580	19	N/A	49	N/A
6/30/2016	559	23	N/A	55	N/A
3/31/2016	546	23	N/A	62	N/A
12/31/2015	542	24	N/A	69	N/A
9/30/2015	537	26	N/A	79	N/A
6/30/2015	529	29	N/A	74	N/A
3/31/2015	520	25	N/A	65	N/A
12/31/2014	510	23	N/A	53	N/A
9/30/2014	497	21	N/A	49	N/A
6/30/2014	483	19	N/A	57	N/A
3/31/2014	464	19	N/A	56	N/A
12/31/2013	449	17	N/A	51	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei MMSI ( 13.8% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van MMSI ( 13.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.2% per jaar).

Hoge groeiwinsten: De winst van MMSI zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van MMSI ( 6.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.7% per jaar).

Hoge groei-inkomsten: De omzet van MMSI ( 6.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen MMSI zal naar verwachting over 3 jaar laag zijn ( 10.3 %).

Merit Medical Systems Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Merit Medical Systems, Inc. Raises Earnings Guidance for the Full-Year 2024

Merit Medical Systems, Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Merit Medical Systems, Inc. Reaffirms Sales Guidance for the Year Ending December 31, 2024

Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report

Merit Medical Systems, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024

Recent updates

Merit Medical Systems - Impressive Momentum

The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)

Merit Medical’s WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients

Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching

Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price

Now 23% overvalued after recent price rise

Merit Medical Systems, Inc. Raises Earnings Guidance for the Full-Year 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Merit Medical Systems, Inc. to Present 6-Month Outcomes from Randomized Arm of WRAPSody Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings

These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely

Merit Medical Systems: Steady Wins The Day

Merit Medical Systems, Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Lead Independent Director notifies of intention to sell stock

Merit Medical Systems, Inc. to Report Q2, 2024 Results on Aug 01, 2024

Merit Medical Systems (NASDAQ:MMSI) Ticks All The Boxes When It Comes To Earnings Growth

Merit Medical: Undervalued With Multiple Growth Drivers In Play

Chief Operating Officer notifies of intention to sell stock

Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price

Merit Medical Launches basixSKY Inflation Device

Merit Medical Elects Silvia M. Perez as New Director

Merit Medical Systems, Inc. Announces Appointment of Joe Wright as President

Merit Medical Systems, Inc. Announce US Food and Drug Administration (FDA) 510(K) Clearance for its Siege Vascular Plug and Launches its Bearing nsPVA Express Prefilled Syringe in the United States and Australia

It Looks Like Shareholders Would Probably Approve Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Compensation Package

Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Merit Medical Systems, Inc. Reaffirms Sales Guidance for the Year Ending December 31, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is Merit Medical Systems (NASDAQ:MMSI) Using Too Much Debt?

Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing

Merit Medical Systems, Inc., Annual General Meeting, May 15, 2024

When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Merit Medical Systems, Inc. Launches the Micro Ace Advanced Micro-Access System

Merit Medical Systems, Inc. to Report Q1, 2024 Results on Apr 30, 2024

CFO & Treasurer recently sold US$479k worth of stock

Independent Director notifies of intention to sell stock

Merit Medical Systems: Solid Performer, Fully Valued

Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report

Full year 2023 earnings: EPS exceeds analyst expectations

Merit Medical Systems, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024

Merit Medical Systems, Inc. Receives FDA 510(K) Clearance for Scout MD Surgical Guidance System

We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease

Lead Independent Director notifies of intention to sell stock

The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing

Merit Medical Systems, Inc. Enrolls First Patient in Merit Medical’s MOTION Study

Merit Medical Systems, Inc. Provides Revenue Guidance for the Year 2023

Merit Medical Systems, Inc. to Report Q4, 2023 Results on Feb 28, 2024

What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E

These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely

What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Merit Medical Systems, Inc. Revises Earnings Guidance for the Fiscal Year Ended December 31, 2023

Consensus EPS estimates increase by 14%

Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Now 21% undervalued after recent price drop

Merit Medical Launches Expanded Maestro Microcatheter Line

Merit Medical Systems, Inc. to Report Q3, 2023 Results on Oct 26, 2023

Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?

Merit Medical Launches the Aspira® Evacuated Drainage Bottle

Chief Operating Officer exercised options and sold US$318k worth of stock

Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing

Chief Operating Officer notifies of intention to sell stock

Merit Medical Systems, Inc. Announces Completion of Enrollment in Its Wawsody Arteriovenous Access Efficacy Pivotal Study

Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Merit Medical Systems, Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?

Merit Medical Systems, Inc. to Report Q2, 2023 Results on Jul 25, 2023

Merit Medical Systems, Inc.(NasdaqGS:MMSI) dropped from Russell Small Cap Comp Value Index

Consensus EPS estimates fall by 12%, revenue upgraded

Merit Medical Systems, Inc. (NasdaqGS:MMSI) acquired Dialysis Product Portfolio and BioSentry Product of AngioDynamics, Inc. (NasdaqGS:ANGO) for $100 million.